Cardiac resynchronization therapy outcomes by sex and QRS duration: insights from AdaptResponse and a Real-world registry.
BACKGROUND Sex-related differences in cardiac resynchronization therapy (CRT) outcomes in heart failure (HF) patients, particularly at shorter QRS durations, remain incompletely defined. We evaluated outcomes by sex and QRS duration in AdaptResponse trial and, pooled with Medtronic product surveillance registry (PSR) d...